R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
复制标题
DOI:
10.1016/j.biopsych.2012.03.022
复制
发表时间:
2012-09-01
影响因子:
10.6
通讯作者:
Newman, Amy Hauck
中科院分区:
文献类型:
--
作者:
Loland, Claus J.;Mereu, Maddalena;Okunola, Oluyomi M.;Cao, Jianjing;Prisinzano, Thomas E.;Mazier, Sonia;Kopajtic, Theresa;Shi, Lei;Katz, Jonathan L.;Tanda, Gianluigi;Newman, Amy Hauck
(±)-Modafinil has piqued interest as a treatment for ADHD and stimulant dependence. The R-enantiomer of modafinil may have unique pharmacological properties that should be further investigated. (±)-Modafinil and its R-(−)- and S-(+)-enantiomers were synthesized and tested for inhibition of [3H]DA uptake and [3H]WIN 35,428 binding in hDAT WT and mutants with altered conformational equilibria. Data were compared to cocaine and the atypical dopamine uptake inhibitor, JHW 007. R- and S-modafinil were also evaluated in microdialysis studies in the mouse NAc shell and in a cocaine discrimination procedure. (±)-, R- and S-Modafinil bind to the DAT and inhibit dopamine uptake less potently than cocaine, with R-modafinil having ~3-fold higher affinity than its S-enantiomer. Molecular docking studies revealed subtle differences in binding modes for the enantiomers. R-modafinil was significantly less potent in the DAT Y156F mutant compared to wild-type DAT, whereas S-modafinil was affected less. Studies with the Y335A DAT mutant showed that the R- and S-enantiomers tolerated the inward facing conformation better than cocaine, which was further supported by MTSET reactivity on the DAT E2C I159C. Microdialysis studies demonstrated that both R- and S-modafinil produced increases in extracellular DA concentrations in the NAc shell less efficaciously than cocaine, and with a longer duration of action. Both enantiomers fully substituted in mice trained to discriminate cocaine from saline. R-modafinil displays an in vitro profile different from cocaine. Future trials with R-modafinil as a substitute therapy with the potential benefit of cognitive enhancement for psychostimulant addiction are warranted.
登录
查看更多内容
DOI:
10.1016/j.pbb.2011.04.017
发表时间:
2011-08
期刊:
Pharmacology, biochemistry, and behavior
影响因子:
--
作者:
Brady KT;Gray KM;Tolliver BK
通讯作者:
Tolliver BK
影响因子:
2.3
作者:
Goulet, M;Miller, GM;Madras, BK
通讯作者:
Madras, BK
影响因子:
4.2
作者:
Cao, Jianjing;Prisinzano, Thomas E.;Okunola, Oluyomi M.;Kopajtic, Theresa;Shook, Matthew;Katz, Jonathan L.;Newman, Amy Hauck
通讯作者:
Newman, Amy Hauck
影响因子:
3.4
作者:
Deroche-Gamonet, V;Darnaudéry, M;Piazza, PV
通讯作者:
Piazza, PV
影响因子:
4.7
作者:
Bisgaard, Heidi;Larsen, M. Andreas B.;Mazier, Sonia;Beuming, Thijs;Newman, Amy Hauck;Weinstein, Hare;Shi, Lei;Loland, Claus J.;Gether, Ulrik
通讯作者:
Gether, Ulrik